Health Care Reform: Gerald Kominski,
professor of health services and director of the UCLA Center for Health
Policy Research in the UCLA Fielding School of Public Health, was interviewed
June 28th by KABC-Channel 7 for a segment about the Supreme
Court's decision on the health care reform law.
New Diet Drug: KCBS-Channel 2 reported
June 27th on Belviq, the first FDA-approved diet drug since 1999.
Dr. David Heber, professor of medicine and director of the UCLA Center for
Human Nutrition in the Fielding School of Public Health, commented on the
impact of the new medication. A UCLA patient from the Center's Risk Factor
Obesity (RFO) program also was interviewed.
Hope for Migraine Sufferers: National
Public Radio's "Morning Edition" interviewed Dr. Charles Flippen, associate
professor of neurology at the David Geffen School of Medicine at UCLA, and
Dr. Andrew Charles, Luskin Chair in Migraine and Headache Studies and vice
chair of neurology, for a story spotlighting treatments available for
migraine. Flippen's patient, Allison Kamerman, management services officer
for the department of health services at the UCLA Fielding School of Public
Health, was also quoted. Charles was also interviewed June 26th on
KCAL-Channel 9 about causes of and treatments for migraines.
Many Migraines Can Be Prevented With Treatments, But Few People Use Them
Gerald Kominski, professor of health services and director of the UCLA
Center for Health Policy Research in the Fielding School of Public Health,
was quoted June 22nd by the Los Angeles Times about the
implications for healthcare if the Supreme Court overturns the Patient
Protection and Affordable Care Act.
How to make U.S. healthcare even worse